Ep 47. Relapse After Cessation Of Weekly Tocilizumab For Giant Cell Arteritis Talking Rheumatology Research podcast

Conteúdo fornecido por British Society for Rheumatology. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por British Society for Rheumatology ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

Talking Rheumatology Research »
Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis

5M ago 10:32

MP3•Home de episódios

Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients.

Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a multidisciplinary approach to managing this condition.

You can read this article [https://doi.org/10.1093/rheumatology/kead604] in Rheumatology.

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

47 episódios

#Fitness #Medicine #British Society For Rheumatology #Rheumatology #Research #Arthritis #Lupus #Journalism #Disease #Science #Myositis #Vasculitis #Bsr